164 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
and regulations for a reporting company.
REMUNERATION AND BENEFITS
Base Salary.
The Company will pay the Executive an annual salary of C$325,000, for full-time … and Governance Professionals of Canada;
Page 3 of 29
Other Benefits. The Company will facilitate the Executive’s enrolment in the Company’s insured benefits
424B3
INM
InMed Pharmaceuticals Inc
13 Nov 23
Prospectus supplement
5:05pm
and consumers who may benefit from cannabinoid-based products. Our approach leverages on the several thousand years’ history of health benefits … for our various programs;
Our ability to explore our manufacturing technologies as processes which may confer certain benefits, either cost, yield
8-K
EX-10.1
n0mc6c0i
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-4.2
oje4lqur2
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-10.3
mc0xmj
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-4.1
e7wrq29 eag8
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-4.3
q9sj9yj4djbyqvy2i
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
424B3
2qiw0rtbbsr1wq 2rgf
15 Dec 22
Prospectus supplement
11:42am
8-K
EX-10.2
gt03mqilcfj
13 Dec 22
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
3:47pm
8-K
EX-4.1
e7kb orqizr
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-4.2
069gdu
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm